BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pande A, Culver DA. Knowing when to use steroids, immunosuppressants or biologics for the treatment of sarcoidosis. Expert Rev Respir Med 2020;14:285-98. [PMID: 31868547 DOI: 10.1080/17476348.2020.1707672] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Drent M, Jessurun NT, Wijnen PA, Bekers O, Bast A. Drug-induced comorbidities in patients with sarcoidosis. Curr Opin Pulm Med 2022. [PMID: 35855576 DOI: 10.1097/MCP.0000000000000889] [Reference Citation Analysis]
2 Spyropoulos G, Domvri K, Manika K, Fouka E, Kontakiotis T, Papakosta D. Clinical, imaging and functional determinants of sarcoidosis phenotypes in a Greek population. J Thorac Dis 2022;14:1941-9. [PMID: 35813723 DOI: 10.21037/jtd-21-1760] [Reference Citation Analysis]
3 Tana C, Drent M, Nunes H, Kouranos V, Cinetto F, Jessurun NT, Spagnolo P. Comorbidities of sarcoidosis. Ann Med 2022;54:1014-35. [PMID: 35441568 DOI: 10.1080/07853890.2022.2063375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
4 Sikjaer MG, Hilberg O, Ibsen R, Løkke A. Sarcoidosis-related mortality and the impact of corticosteroid treatment: A population-based cohort study. Respirology 2022. [PMID: 35016255 DOI: 10.1111/resp.14202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Melani AS, Bigliazzi C, Cimmino FA, Bergantini L, Bargagli E. A Comprehensive Review of Sarcoidosis Treatment for Pulmonologists. Pulm Ther 2021;7:325-44. [PMID: 34143362 DOI: 10.1007/s41030-021-00160-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Saketkoo LA, Russell AM, Jensen K, Mandizha J, Tavee J, Newton J, Rivera F, Howie M, Reese R, Goodman M, Hart P, Strookappe B, De Vries J, Rosenbach M, Scholand MB, Lammi MR, Elfferich M, Lower E, Baughman RP, Sweiss N, Judson MA, Drent M. Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes. Diagnostics (Basel) 2021;11:1089. [PMID: 34203584 DOI: 10.3390/diagnostics11061089] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
7 Entrop JP, Kullberg S, Grunewald J, Eklund A, Brismar K, Arkema EV. Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids. ERJ Open Res 2021;7:00028-2021. [PMID: 34046487 DOI: 10.1183/23120541.00028-2021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
8 Rossides M, Kullberg S, Di Giuseppe D, Eklund A, Grunewald J, Askling J, Arkema EV. Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective 'target trial' emulated with Swedish real-world data. Respirology 2021;26:452-60. [PMID: 33398914 DOI: 10.1111/resp.14001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
9 Hang W, Chen C, Seubert JM, Wang DW. Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes. Signal Transduct Target Ther 2020;5:287. [PMID: 33303763 DOI: 10.1038/s41392-020-00360-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
10 Vizel AA, Culver DA, Vizel IY, Shakirova GR, Bakunina EA. Assessment of the effect of alpha-tocopherol on the course of newly diagnosed pulmonary sarcoidosis: a comparative study. Tuberk bolezni lëgk 2020;98:33-40. [DOI: 10.21292/2075-1230-2020-98-10-33-40] [Reference Citation Analysis]
11 Quijano-Campos JC, Williams L, Agarwal S, Tweed K, Parker R, Lalvani A, Chiu YD, Dorey K, Devine T, Stoneman V, Toshner M, Thillai M. CASPA (CArdiac Sarcoidosis in PApworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort study. BMJ Open Respir Res 2020;7:e000608. [PMID: 33037032 DOI: 10.1136/bmjresp-2020-000608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Almagro L, Lemos R, Makowski K, Rodríguez H, Ortiz O, Cáceres W, Herranz MÁ, Molero D, Martínez‐álvarez R, Suárez M, Martín N. [60]Fullerene Hybrids Bearing “Steroid Wings”: A Joined Experimental and Theoretical Investigation. Eur J Org Chem 2020;2020:5926-37. [DOI: 10.1002/ejoc.202000989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Sellarés J, Francesqui J, Llabres M, Hernandez-gonzalez F, Baughman RP. Current treatment of sarcoidosis. Current Opinion in Pulmonary Medicine 2020;26:591-7. [DOI: 10.1097/mcp.0000000000000720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Jain R, Yadav D, Puranik N, Guleria R, Jin JO. Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments. J Clin Med 2020;9:E1081. [PMID: 32290254 DOI: 10.3390/jcm9041081] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 20.0] [Reference Citation Analysis]